Guggenheim Capital’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13,480
| Closed | -$98K | – | 1927 |
|
|
2022
Q2 | $98K | Sell |
13,480
-5,423
| -29% | -$39.4K | ﹤0.01% | 2009 |
|
|
2022
Q1 | $245K | Sell |
18,903
-17,065
| -47% | -$221K | ﹤0.01% | 1961 |
|
|
2021
Q4 | $574K | Sell |
35,968
-52,482
| -59% | -$838K | ﹤0.01% | 1624 |
|
|
2021
Q3 | $1.42M | Buy |
88,450
+7,897
| +10% | +$127K | 0.01% | 1230 |
|
|
2021
Q2 | $1.11M | Buy |
80,553
+32,670
| +68% | +$452K | 0.01% | 1430 |
|
|
2021
Q1 | $699K | Sell |
47,883
-28,522
| -37% | -$416K | ﹤0.01% | 1548 |
|
|
2020
Q4 | $1.33M | Buy |
76,405
+66,366
| +661% | +$1.15M | 0.01% | 1176 |
|
|
2020
Q3 | $184K | Buy |
+10,039
| New | +$184K | ﹤0.01% | 1804 |
|
|
2018
Q2 | – | Sell |
-15,729
| Closed | -$173K | – | 2406 |
|
|
2018
Q1 | $173K | Sell |
15,729
-519
| -3% | -$5.71K | ﹤0.01% | 2632 |
|
|
2017
Q4 | $142K | Sell |
16,248
-732
| -4% | -$6.4K | ﹤0.01% | 2593 |
|
|
2017
Q3 | $227K | Buy |
16,980
+2,366
| +16% | +$31.6K | ﹤0.01% | 2595 |
|
|
2017
Q2 | $210K | Buy |
+14,614
| New | +$210K | ﹤0.01% | 2635 |
|